PHARMACOVIGILANCE CHALLENGES IN BIOSIMILARS


This session of the Biosimilars 2021 will investigate the future and FDA activities that have just been declared to incorporate upgraded following and follow-up of post promoting observation issues, arranged enhancements in AERS, and pilots of new post market drug-monitoring strategies and ADR related issues. Biosimilar rules for pharmacovigilance practice and pharmaco epidemiology are the focuses that will be laid emphasis  in this session. U.S. normal yearly spending development from 2002 to 2007 was 16% for biologics, contrasted and 3.7% for drugs. In same extent pharmacovigilance for biosimilars has been nearly more than other pharmaceutical items.




  • Current issues in biosimilars pharmacovigilance


  • Unfriendly medication responses with biologics and biosimilar items


  • Recognition and assessment of medication security signals


  • Job of pharma businesses in the improvement of pharmacovigilance framework


  • Great pharmacovigilance practice and pharmacoepidemiology



 


    Related Conference of PHARMACOVIGILANCE CHALLENGES IN BIOSIMILARS

    April 30-30, 2021

    2nd International Conference on Nucleic Acids

    London, UK
    May 17-18, 2021

    11th World Glycobiology Congress

    Vienna, Austria
    July 26-27, 2021

    5th International Conference on Bioscience and Biotechnology

    London, Aland Islands
    March 15-16, 2021

    12th Tissue Repair and Regeneration Congress

    Dubai, UAE
    July 30-30, 2021

    Glycobiology Biochem Conference 2021

    London, UK
    August 17-18, 2021

    23rd Global Biotechnology Congress

    Rome, Italy
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland
    December 01-02, 2021

    18th International Conference on Metabolomics and Proteomics

    Frankfurt, Germany
    December 03-04, 2021

    International Conference on Biotechnology

    Singapore, Singapore

    PHARMACOVIGILANCE CHALLENGES IN BIOSIMILARS Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in